Navigation Links
Synthetic Genomics, Inc. and Integrated DNA Technologies, Inc. Sign Agreement to Manufacture, Market, and Commercialize Small Synthetic Gene Products Using SGI Technology
Date:2/2/2012

LA JOLLA, Calif. and CORALVILLE, Iowa, Feb. 2, 2012 /PRNewswire/ -- Synthetic Genomics, Inc. (SGI), a privately held company commercializing and developing genomic-driven solutions to solve a variety of global needs, and Integrated DNA Technologies, Inc. (IDT), the world leader in production and supply of oligonucleotides, today jointly announced that they have entered into an agreement to manufacture, market, and commercialize small synthetic gene products. The financial details of the agreement were not disclosed.

Specifically, SGI and IDT will work together to construct custom, synthetic, double-stranded nucleic acids up to 5 kb. IDT will use its custom oligonucleotide manufacturing expertise, including its recently launched gBlocks Gene Fragments product line, in combination with SGI's proprietary technologies to efficiently assemble small gene constructs.

"We believe that our agreement with IDT is a key component to advance our synthetic DNA business," said J. Craig Venter, Ph.D., Founder and Chief Executive Officer, SGI. "We look forward to working with the market leader IDT in developing important products for the life sciences community."  

"We are pleased to be partnering with Synthetic Genomics. Through this collaboration we plan to apply SGI's cutting edge technologies to create more affordable, efficient gene synthesis products that can be delivered more quickly to the synthetic biology community," added Dr. Joe Walder, Founder and Chief Executive Officer, IDT.

In May 2010 J. Craig Venter Institute (JCVI) researchers announced the successful construction of the first self-replicating synthetic bacterial cell, work that took years to complete and was enabled only through development of new tools and technologies. SGI sponsored this work at JCVI and controls the licensing of the technologies.

About Synthetic Genomics Inc.
SGI, a privately held company founded in 2005, is dedicated to developing and commercializing genomic-driven solutions to address a wide range of global challenges. The company is focused on several key research and business programs including: developing algae biofuels in alliance with Exxon Mobil Research and Engineering Company, microbial-enhanced hydrocarbon recovery and conversion through an agreement with BP, new and improved food and nutritional products, and clean water technologies. SGI is also involved in synthetically derived vaccine development through Synthetic Genomic Vaccines Inc. (SGVI), a company co-founded with the J. Craig Venter Institute; and to developing sustainable crops and agricultural products through Agradis Inc., a company co-founded with Plenus S.A. de C.V. For more information go to: www.syntheticgenomics.com.

About IDT
Integrated DNA Technologies, Inc. (IDT) is the largest supplier of custom nucleic acids in the world, serving the areas of academic research, biotechnology, clinical diagnostics and pharmaceutical development. IDT's primary business is the manufacture of custom primers, probes, and genes for research and diagnostic applications. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; and Leuven, Belgium. For more information, visit www.idtdna.com.

SGI Media Contact:
Heather Kowalski, hkowalski@syntheticgenomics.com, 858-361-0466

IDT Media Contact:
Stephen Gunstream, sgunstream@idtdna.com, 319-626-9696


'/>"/>
SOURCE Synthetic Genomics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. D1 Sports Training Facilities Adopt TurfAide(TM) Antimicrobial to New Synthetic Turf Fields from AstroTurf(R)
2. First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology
3. Novus Scientific Receives FDA Clearance for TIGR(TM) Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
4. AmpVacs a Broadly Protective Synthetic Influenza A Vaccine
5. Novus Scientific Announces the Sales Launch for TIGR™ Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
6. Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Companys First Synthetic Internal Use Sealant
7. Aubrey Inc. Releases New Advanced Biosynthetic Wound Care Product AWBAT Plus
8. Reportlinker Adds Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
9. Novus Scientific Announces the Worlds 1st Long-Term Absorbable Mesh as an Alternative to Non-Absorbable Synthetic Mesh
10. Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines Potential to Help Ensure Nations Food Supply Safety
11. Synthetic Genomics Vaccines, Inc. Hires Vaccine Executive Sammy J. Farah as President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... FRANCISCO , May 2, 2016 ... expected to reach USD 11.1 billion by 2024, ... View Research, Inc. Major drivers of the sonography ... therapeutic areas and government recommendations for periodic ultrasound ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) ...
(Date:4/29/2016)... 2016 ReportsnReports.com adds "Pulmonary ... research report that provides an overview of the ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Pulmonary ...
(Date:4/29/2016)... , April 29, 2016 ... Directeur Financier Sanofi, leader ... publie ses résultats pour le premier ... Groupe, Jérôme Contamine, commente les résultats ... les perspectives pour le reste de ...
Breaking Medicine Technology:
(Date:5/3/2016)... , ... May 03, 2016 , ... Ogawa World USA ... its user friendly Samsung tablet and exclusive Smart Application. The Smart 3D combines the ... each massage with a customized user profile and specialized massage program, each user has ...
(Date:5/3/2016)... NY (PRWEB) , ... May 03, 2016 , ... ... for the healthcare industry, announced today that Legacy Health is expanding its use ... Works platform), after a highly successful initial proof of concept. The Portland, Oregon ...
(Date:5/3/2016)... VA (PRWEB) , ... May 03, 2016 , ... ... provider of innovative information technology (IT) solutions and digital consulting services to the ... Information Technology Services (EITS) Indefinite Delivery / Indefinite Quantity (ID/IQ) contract in support ...
(Date:5/3/2016)... , ... May 03, 2016 , ... Huntington Beach ... type of surgical procedure that can be used to diagnose and treat joint problems. ... be inserted. These instruments include a special lighting system and lens that illuminate and ...
(Date:5/3/2016)... ... ... Branches, Inc. is proud to have been selected as a Macy’s grant ... Miami. Macy’s is a wonderful community partner and has helped to support Branches’ student ... and academic support to elementary students 5 days a week. Summer Shade, a 7 ...
Breaking Medicine News(10 mins):